SPONSOR
National Heart, Lung, and Blood Institute (NHLBI)
Total Trials
8
Recruiting
8
Phases
N/A
Conditions studied: Healthy SubjectsClonal Hematopoiesis of Indeterminate PotentialClonal Cytopenia of Undetermined SignificanceMetabolic DiseaseObesityLi-Fraumeni SyndromeCardiomyopathyAtherosclerosisInflammatory DiseaseCoronary Disease
National Heart, Lung, and Blood Institute (NHLBI) is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Healthy Subjects, Clonal Hematopoiesis of Indeterminate Potential, Clonal Cytopenia of Undetermined Significance, Metabolic Disease.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National Heart, Lung, and Blood Institute (NHLBI)
How many clinical trials has National Heart, Lung, and Blood Institute (NHLBI) sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by National Heart, Lung, and Blood Institute (NHLBI), of which 8 are actively recruiting participants. These trials cover conditions including Healthy Subjects, Clonal Hematopoiesis of Indeterminate Potential, Clonal Cytopenia of Undetermined Significance. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National Heart, Lung, and Blood Institute (NHLBI) research focus on?
National Heart, Lung, and Blood Institute (NHLBI) clinical trials span Healthy Subjects, Clonal Hematopoiesis of Indeterminate Potential, Clonal Cytopenia of Undetermined Significance, Metabolic Disease, Obesity, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a National Heart, Lung, and Blood Institute (NHLBI) clinical trial?
To participate in a National Heart, Lung, and Blood Institute (NHLBI) trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National Heart, Lung, and Blood Institute (NHLBI) trials with current recruitment status updated daily.
Clinical Trials by National Heart, Lung, and Blood Institute (NHLBI)
NCT02417714
Recruiting
Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Healthy Subjects
NCT04102423
Recruiting
CHIP/CCUS Natural History Protocol
Clonal Hematopoiesis of Indeterminate Potential
NCT01143454
Recruiting
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
Metabolic Disease
NCT03288207
Recruiting
Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments
Obesity
NCT01621594
Recruiting
Evaluating New Radiation Techniques for Cardiovascular Imaging
Coronary Disease
NCT01927783
Recruiting
Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention
Cardiovascular Disease
NCT07137429
Recruiting
Platelet Volunteers, Longitudinal and Multi-omic Study
Thrombosis
NCT05213572
Recruiting
Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies
Mortality in Sickle Cell
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology